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Abstract
Radiomics is a new concept that has been functioning in medicine for only a few years. This idea, created recently, 
relies on processing innumerable quantities of metadata acquired from every examination, followed by extraction 
thereof from relevant imaging examinations, such as computer tomography (CT), magnetic resonance imaging (MRI), 
or positron emission tomography (PET) images, by means of appropriate created algorithms. The extracted results 
have great potential and broad possibilities of application. Thanks to these we can verify efficiency of treatment, pre-
dict locations of metastases of tumours, correlate results with histopathological examinations, or define the type of 
cancer more precisely. In effect, we obtain more personalised treatment for each patient, which is extremely impor-
tant and highly recommendable in the tests and applicable treatment therapies conducted nowadays. Radiomics is 
a non-invasive and high efficiency post-processing method. This article is intended to explain the idea of radiomics, 
the mechanisms of data acquisition, existing possibilities, and the challenges incurred by radiologists and physicians 
at the stage of making diagnosis or conducting treatment. 
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Introduction
Contemporary medicine is characterised by the search of 
objective data, parameters, and factors underlying many 
diseases, particularly cancers or autoimmunological dis-
eases (Lavelle et al. 2015). Detailed knowledge of the ge-
netic code and the development of genomic science allow 
to us discover mutations characteristic of many patholo-
gies, e.g. breast cancer in patients with the BRCA-1 muta-
tion [1]. The discovery of the basic processes occurring in 
sick cells allowed the invention of biological medications 
that modify the metabolic pathways in autoimmunological 
diseases, e.g. TNF-α inhibitors in the treatment of rheu-
matic diseases [2]. Various types of proteins, cytokines, 
genetic mutations, etc. are so-called biomarkers, which 
permit the prediction of the likelihood of occurrence of 
a disease, its course (all those at a high rate of probabili-
ty), and define its prognosis [3]. Imaging diagnostics are 
an indispensable tool, providing a lot of information about 
the patient’s state and the disease [4].
In oncology, neurology, or autoimmunological dis-
eases, modern imaging technologies such as computer 
tomography (CT), magnetic resonance imaging (MRI), 
positron emission tomography (PET), scintigraphy, digital 
radiography (CXR), and ultrasonography (US) allow us to 
accurately define the occurrence and assess the degree of 
advancement of anomalies [4]. The images obtained are 
interpreted by qualified personnel, and the accuracy of 
their assessment depends on the knowledge possessed, 
experience, and the quality of equipment and advanced 
post-processing software. Medical images, stored as dig-
ital files, are not only a set of images that can be “viewed 
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and interpreted”, but they also form a vast resource of bio-
medical data saved in the form of a complex numerical 
code [5]. These data include hundreds, or sometimes even 
thousands, of parameters – features unique to selected 
pathologies [6]. 
For the first time, specific parameters were used in 
computer-aided detection and diagnosis software (CAD), 
amongst others in breast cancer, lung tumour diagnostics, 
or in automatic spine segmentation systems [7]. Currently, 
these applications are the basic furnishing of packages e.g. 
for assessment of focal changes in lungs or liver, standard-
ised according to the RECIST 1.1 protocol [8]. 
Discoveries at the level of basic science, which initiated 
the creation of specific areas such as proteomics, genomics, 
and metabolomics, inspired the search for image biomark-
ers, characteristic features for selected disease entities [9]. 
The term radiomics was first introduced in 2010; it is de-
rived from the name of the sector (radiology) and a char-
acteristic suffix found in the fields of basic sciences (omics) 
[10, 11]. Since that time, we have observed a significant 
growth of interest in quantitative imaging biomarkers.
The aim of this article is to review the available methods 
of advanced post-processing and to approximate the results 
of the examinations using contemporary radiomics.
This systematic review of the literature was conduct-
ed based on the PubMed, Clinical Key, and ScienceDirect 
databases, using the following key words: radiomic or 
radiomics. The analysis covered the works developed be-
tween January 2007 and July 2017, available in the form of 
full articles written in English. Out of 225 articles found, 
the 15 most recent publications were used in further anal-
ysis; these were also the most extensive and included the 
most information, which allowed a reliable approximation 
of the subject of radiomics and its possibilities. 
Radiomics
Radiomic assessment of images is a complex process, in 
which at least five major stages should be highlighted: 
acquisition of medical images, selection of the region of 
interest (ROI), three-dimensional modelling and segmen-
tation of the region, analysis of features, and finally inte-
gration with the results of other assessments (clinical, lab-
oratory data, or genetic tests) [5]. The key for each stage 
is to follow the standards and the adopted algorithms in 
order to be able to reproduce the achieved effect and to 
implement it in other healthcare centres. 
Medical imaging 
The basis for radiomics is CT and MR examinations, while 
PET and more advanced PET/CT or PET/MR to a lesser 
extent [12]. Although acquisition of good quality, unified 
imaging data does not constitute any problem in every-
day clinical practice, it is a significant challenge in terms 
of cooperation between individual healthcare centres [5]. 
Manufacturers of radiological equipment apply diverse 
techniques for image acquisition, reduction of radiation, 
or post-processing techniques, which may affect the image 
parameters and in consequence may give various results 
of radiomic analysis. 
Region of interest and 3D rendering
Determination of the region of interest allows us to extract 
that fragment of the image from the entire examination – 
i.e. a virtual tissue – which is affected by the disease. A per-
fect example is the selective choice of the tumour region 
in lung cancer [13]. For this purpose, manual and, cur-
rently more frequently, automatic programmes of change 
segmentation are used – CAD. Numerous studies confirm 
the credibility and high reproducibility of automatic and 
semi-automatic diagnosis-aiding programmes [1-16]. 
These programmes recognise the density and structure of 
the tissue and “resect” it from the healthy tissues [17]. That 
is followed by 3D models, which work as a material for 
further analysis of features. 
Radiomic features
Radiomics enables quantitative isolation of image fea-
tures, which may be grouped within several cognitive and 
statistical levels [5, 12]. The first level, which comprises se-
mantic features (shape, size, location of abnormality, degree 
of its vascularisation, spicularity, infiltration of the region), 
which are used in everyday clinical practice [6]. The second 
level is associated with quantitative parameters of each vox-
el – the smallest volumetric units in three-dimensional im-
ages [12]. It presents the distribution of numerical values of 
individual voxels in the form of a histogram, returning such 
parameters as the average, maximum, minimum, standard 
deviation, kurtosis, obliquity, entropy, etc. The third level, 
statistical analysis of the higher order structure, shows the 
relationships (similarities and counterparts) between the 
neighbouring voxels. Image structure analysis was first 
proposed in 1973 by Haralick et al. in the study: Textural 
features for image classification [18]. 
Dozens of various image texture analysis methods are 
available currently, of which radiomics uses the following: 
the grey-level co-occurrence matrix (GLCM), grey-level 
run length matrix (GLRLM), grey-level size zone matrix 
(GLSZM), neighbourhood grey-tone difference matrix 
(NGTDM), fractal features analysis and discrete wavelet 
transform (DWT), Minkowski functionals, and Laplace 
transforms [5].
GLCM defines the relationships between voxel pairs and 
the frequency of occurrence of similar pairs in ROI [12]. 
GLRLM returns the quantity of adjacent voxels with the 
equal level of grey [19]. GLSZM refers to the level of ROI 
uniformity [6]. NGTDM is a mono-dimensional measure 
of differences between all grey values of individual pixels.
[6] NGTD defines the contrast, roughness, complexity, and 
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texture strength. Fractals characterise self-resemblance and 
roughness of the surface lesion. The list of statistical trans-
formations and capabilities to distinguish image features 
seems to be indefinite, particularly in combination with the 
abundance of imaging techniques and the values specific to 
the selected pathologies. Another method of extraction of 
desirable information is the use of spatial filters; for exam-
ple, edge filtering techniques, Laplacian of Gaussian filter, 
entropy filter etc. [12]. A detailed description of individual 
techniques goes far beyond the scope of this work. 
Data integration 
The last stage of this complex process is integration of 
data acquired from other sources, amongst others: clin-
ical data, laboratory results, presence of antibodies, and 
specific proteins [20]. The creation of enormous databas-
es and application of multi-factorial statistical analyses is 
intended to facilitate diagnosis of diseases, establish prog-
nosis, and, as a further consequence, to help in the cre-
ation of targeted screening programmes or medications 
preventing illness [21]. 
Current tests
The radiomics field is an extremely rapidly developing 
area of contemporary medicine, which penetrates many 
of its sectors and closely related sciences. The database 
of scientific works is continuously increasing, while radi-
omics is dynamically conquering new areas. This part of 
the article will present the most important research and 
the latest overview of publications put forward in 2016-
2017 in the field of oncology, which is the most devel-
oped and represented domain of medicine in reviews of 
articles conducted on a large number of patients (at least 
100), which will allow objective results to be obtained. 
The selected literature refers to the tests conducted using 
computer tomography – a method that currently features 
the most extensive resource of data. In the study con-
ducted on a group of 127 patients who were analysed for 
pathological response during neo-adjuvant chemotherapy 
within the course of NSCLS treatment [22], a radiomic 
predictive value of distinct features was observed, contra-
ry to classical imaging. 
In the next study conducted on a group of 200 pa-
tients, who were examined with respect to prediction of 
metastases to lymph nodes in the course of colorectal 
cancer [23], it was also possible to achieve success and to 
create an adequate model (normogram), which pre-opera-
tively facilitates prediction of occupation of specific lymph 
nodes in each patient individually. 
A study associated with EGFR mutation status in lung 
adenocarcinoma, conducted on 298 patients, allowed the 
presence of mutations to be foreseen, by means of de-
signing of a model analysing five features, together with 
a summary of the risk factors. With such a normogram, 
there is tremendous potential to improve the differentia-
tion of EGFR type from wild type [24].
In research concerning HNSC, which was based on 
two groups consisting of 101 and 95 subjects respective-
ly, it was possible to characterise prognostic factors and 
adequate methods of data acquisition in order to achieve 
a final estimate of life expectancy of patients with head 
and neck cancer. The results achieved allow precise plan-
ning of treatment [25].
In retrospective research conducted on a group of 
215 patients after partial hepatectomy due to hepatocel-
lular cancer (HCC), data were collected, on the basis of 
which an appropriate algorithm was designed. The model 
was extended with additional parameters such as clini-
cal factors, which alone do not give a precise response on 
HCC recurrence. As a result, a tool was found that enables 
discovery of early recurrence of the disease much earlier 
than relying solely on clinical data [13].
Hopes and concerns 
A challenge for 21st century medicine is the collection of 
great amounts of information about patients and diseas-
es, across numerous databases and reports, referred to as 
Big Data [26, 27]. Creators of the largest programmes, 
launched amongst others in the USA, the Netherlands, 
and France, emphasise the main limitation: lack of coher-
ence of data originating from different institutions [5]. 
Implementation of standardised protocols is an extreme-
ly important element, which will allow the extraction of 
representative, reliable, and, most of all, repeatable results 
[12]. The creation of common, coherent databases is one 
of the greatest challenges faced by contemporary medi-
cine. 
Synthesis of data obtained from standard clinical tests, 
histopathological, genetic, and, ultimately, radiological 
results will allow the development of more personalised 
medicine [26]. Discovery of the rules and patterns en-
coded in images give hope for better recognition of the 
pathophysiology of cancers, amongst others, and their 
discovery at earlier stages, as well as for improvement 
of treatment efficiency. Use of radiological tests being 
non-invasive screening methods, in combination with 
radiomics, may enable a very early and precise diagnosis, 
and individualised patient care. 
The enormous amount of information is also asso-
ciated with a risk of overfitting and overlooking more 
general information. Over-concentration on numbers, 
parameters, and indicators may cause dehumanisation of 
medicine.
Sceptics of the 20th century expected radiology to be 
over by the year 2020 [28]. The discovery of radiomics 
and use of advanced post-processing techniques is proof, 
which not only contradicts the decline of this domain but 
also indicates its uncapped potential for further develop-
ment.
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Conclusions
Radiomics is a relatively new branch, allowing abun-
dant new information on many diseases. 
Use of radiomic analysis techniques in cancer, and 
haematological and autoimmunological diseases may help 
to make earlier relevant diagnosis, adjust the best available 
therapy, and improve the patient’s quality of life. 
Currently, an important challenge for this domain is 
to develop standardised clinical protocols, reproducible 
across various healthcare institutions.
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